Deutsche Bank’s EnteroMedics Inc. ETRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-2,709
| Closed | -$4K | – | 5393 |
|
|
2017
Q3 | $4K | Buy |
2,709
+800
| +42% | +$2.36K | ﹤0.01% | 4771 |
|
|
2017
Q2 | $9K | Buy |
1,909
+900
| +89% | +$4.48K | ﹤0.01% | 4686 |
|
|
2017
Q1 | $5K | Buy |
+1,009
| New | +$7.46K | ﹤0.01% | 4719 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 5356 |
|
|
2016
Q3 | – | Sell |
-1,736
| Closed | -$23.6K | – | 5631 |
|
|
2016
Q2 | $35K | Buy |
+1,736
| New | +$79.5K | ﹤0.01% | 4568 |
|
|
2015
Q4 | – | Sell |
-756
| Closed | -$206K | – | 5664 |
|
|
2015
Q3 | $206K | Buy |
756
+751
| +15,020% | +$240K | ﹤0.01% | 3789 |
|
|
2015
Q2 | $3K | Hold |
5
| – | – | ﹤0.01% | 5220 |
|
|
2015
Q1 | $4K | Hold |
5
| – | – | ﹤0.01% | 4945 |
|
|
2014
Q4 | $7K | Hold |
5
| – | – | ﹤0.01% | 5826 |
|
|
2014
Q3 | $6K | Hold |
5
| – | – | ﹤0.01% | 5526 |
|
|
2014
Q2 | $7K | Buy |
+5
| New | +$9.35K | ﹤0.01% | 5586 |
|
|
2013
Q4 | – | Sell |
-141
| Closed | -$184K | – | 6181 |
|
|
2013
Q3 | $184K | Buy |
141
+75
| +114% | +$87.3K | ﹤0.01% | 4158 |
|
|
2013
Q2 | $78K | Buy |
+66
| New | +$69.7K | ﹤0.01% | 4340 |
|
Other funds holding ETRM
Deutsche Bank's ETRM Position: Q4 2017 in Review
Deutsche Bank sold out of EnteroMedics Inc. (ETRM) in Q4 2017, closing a stake of 2,709 shares — an estimated $4K sold.
Deutsche Bank first reported a position in ETRM in Q2 2013 and held it in 12 quarters. The position peaked at $206K in Q3 2015. 1 fund tracked by Wall St. Rank holds ETRM as of Q4 2017.
- Deutsche Bank reported no remaining EnteroMedics Inc. position as of Q4 2017 after selling out during the quarter.
- Deutsche Bank sold 2,709 EnteroMedics Inc. shares in Q4 2017, an estimated $4K.
- Deutsche Bank first reported a position in EnteroMedics Inc. in Q2 2013 and held it in 12 quarters.
- Deutsche Bank's EnteroMedics Inc. position peaked at $206K in Q3 2015.
- 1 fund tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2017.
Based on Deutsche Bank's 13F filing for Q4 2017, filed 14 Feb 2018.